miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5

被引:45
|
作者
Zhou, Wenhui [1 ,2 ,3 ,4 ,5 ]
Song, Fangfang [4 ,5 ,6 ,7 ]
Wu, Qiuju [4 ,5 ,6 ,7 ]
Liu, Rong [4 ,5 ]
Wang, Lulu [2 ,3 ]
Liu, Cuicui [2 ,3 ]
Peng, You [2 ,3 ]
Mao, Shuqin [8 ]
Feng, Jing [1 ,2 ,3 ]
Chen, Ceshi [4 ,5 ]
机构
[1] Southern Med Univ, Clin Coll 3, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai, Peoples R China
[3] Southern Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai, Peoples R China
[4] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan Province, Peoples R China
[5] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan Province, Peoples R China
[6] Jinzhou Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai, Peoples R China
[7] Jinzhou Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai, Peoples R China
[8] Hubei Univ Med, Affiliated Taihe Hosp, Shiyan, Hubei Province, Peoples R China
来源
PLOS ONE | 2017年 / 12卷 / 04期
关键词
PANCREATIC DUCTAL ADENOCARCINOMA; TRANSCRIPTION FACTOR; PROTEASOME DEGRADATION; PROLIFERATION; SURVIVAL; MICRORNA-217; CARCINOMA; EXPRESSION; KINASE;
D O I
10.1371/journal.pone.0176395
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Triple negative breast cancer (TNBC) is one of the most aggressive breast cancers without effective targeted therapies. Numerous studies have implied that KLF5 plays an important roles in TNBC. How is KLF5 regulated by microRNAs has not been well studied. Here, we demonstrated that miR-217 down-regulates the expression of KLF5 and KLF5's downstream target gene FGF-BP and Cyclin D1 in TNBC cell lines HCC1806 and HCC1937. Consequently, miR-217 suppresses TNBC cell growth, migration, and invasion. MiR-217 suppresses TNBC, at least partially, through down-regulating the KLF5 expression. These results suggest that the miR-217-KLF5 axis might serve as a potential target for treatment of TNBC.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
    Shi, Peiguo
    Liu, Wenjing
    Tala
    Wang, Haixia
    Li, Fubing
    Zhang, Hailin
    Wu, Yingying
    Kong, Yanjie
    Zhou, Zhongmei
    Wang, Chunyan
    Chen, Wenlin
    Liu, Rong
    Chen, Ceshi
    CELL DISCOVERY, 2017, 3
  • [2] Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
    Peiguo Shi
    Wenjing Liu
    Haixia Tala
    Fubing Wang
    Hailin Li
    Yingying Zhang
    Yanjie Wu
    Zhongmei Kong
    Chunyan Zhou
    Wenlin Wang
    Rong Chen
    Ceshi Liu
    Cell Discovery, 3
  • [3] Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
    Shi, Peiguo
    Zhou, Zhongmei
    Liu, Rong
    Chen, Ceshi
    CANCER RESEARCH, 2017, 77
  • [4] MiR-630 inhibits cells migration and invasion by targeting SOX4 in triple-negative breast cancer
    Liu, Yun-Xiao
    Zhao, Li-Ping
    Zhang, Ya-Li
    Dong, Yan-Yan
    Ren, Hua-Yan
    Diao, Ke-Xin
    Mi, Xiao-Yi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9097 - 9105
  • [5] MiR-217 Inhibits Proliferation, Migration, and Invasion by Targeting SIRT1 in Osteosarcoma
    He, Shaoxuan
    Wang, Zhihua
    Tang, Hao
    Dong, Junjie
    Qu, Yongzhou
    Lv, Jia
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (04) : 264 - 270
  • [6] miR-21 promotes cell migration and invasion of hepatocellular carcinoma by targeting KLF5
    Wang, Jian
    Chu, Yanfeng
    Xu, Mei
    Zhang, Xiumei
    Zhou, Yumei
    ONCOLOGY LETTERS, 2019, 17 (02) : 2221 - 2227
  • [7] miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer
    Xiong, Huaping
    Yan, Ting
    Zhang, Weijie
    Shi, Fangfang
    Jiang, Xuesong
    Wang, Xiaohua
    Li, Shoushan
    Chen, Ying
    Chen, Cheng
    Zhu, Yichao
    CELLULAR SIGNALLING, 2018, 44 : 33 - 42
  • [8] Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT
    Kong, Lingkai
    He, Qinyu
    Ma, Ding
    Shi, Weiwei
    Xin, Qilei
    Jiang, Chunping
    Wu, Junhua
    FEBS OPEN BIO, 2024, 14 (05): : 831 - 842
  • [9] MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer
    Hou, Lingmi
    Chen, Maoshan
    Yang, Hongwei
    Xing, Tianyong
    Li, Jingdong
    Li, Guangwu
    Zhang, Lina
    Deng, Shishan
    Hu, Jiani
    Zhao, Xiaobo
    Jiang, Jun
    MEDICAL SCIENCE MONITOR, 2016, 22 : 3666 - 3672
  • [10] Mifepristone suppresses triple-negative breast cancer cell growth and cancer stem cell maintenance via down-regulating KLF5 expression
    Liu, R.
    Chen, C.
    CANCER RESEARCH, 2013, 73